CovidResearchTrials by Shray Alag

CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)

Report for D016055: Urinary Retention NIH

(Synonyms: Urinary Retention)

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (1)

Name (Synonyms) Correlation
drug1459 Medtronic Interstim II Model 3058 Neurostimulator Wiki 1.00

Correlated MeSH Terms (1)

Name (Synonyms) Correlation
D000077295 Urinary Bladder, Underactive NIH 1.00

Correlated HPO Terms (1)

Name (Synonyms) Correlation
HP:0000016 Urinary retention HPO 1.00

There is one clinical trial.

Clinical Trials

1 Previously Implanted Pudendal Nerve Stimulation

This study seeks to examine the response of the bladder to different pudendal nerve stimulation frequencies, by studying patients who have been previously-implanted with pudendal nerve neurostimulators.

NCT04473469 Urinary Retention Underactive Bladder Device: Medtronic Interstim II Model 3058 Neurostimulator
MeSH:Urinary Retention Urinary Bladder, Underactive
HPO:Urinary retention

Primary Outcomes

Description: At least 50% of participants

Measure: Evoked bladder contractions of at least 20 centimeters of water (cmH2O)

Time: Visit 1, approximately 1 week after consent

HPO Nodes

HP:0000016: Urinary retention
Genes 17
SP110 HMBS APRT BNC2 VANGL1 KCNJ18 ACTG2 PRNP STAT6 TGFB1 NAB2 ALDH18A1 COL7A1 CACNA1S ALDH18A1 GABRA3 HMBS
Protein Mutations 0
SNP 0